GGrantIndex
Sort

64,565 grants matching drug discovery

Cancer Center Support Grant (CCSG)

$487,500
Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · P30 · FY2020 · CA

MAOI-inspired activity probes to translate epigenetics and genetics into drugs

$487,500
Megan L Matthews · University Of Pennsylvania · DP1 · FY2021 · DA

MAOI-inspired activity probes to translate epigenetics and genetics into drugs

$487,500
Megan L Matthews · University Of Pennsylvania · DP1 · FY2024 · DA

Optimization and Characterization of "MYC Degraders" for Pediatric Medulloblastoma

$487,500
Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R33 · FY2022 · NS

Discovery of small molecule regulators of atrial cardiomyocyte action potential duration to restore normal cardiac rhythm in atrial fibrillation

$487,500
Alexandre Romain Colas · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · HL

Discovery of small molecule regulators of atrial cardiomyocyte action potential duration to restore normal cardiac rhythm in atrial fibrillation

$487,500
Alexandre Romain Colas · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · HL

HTS Assay for P. falciparum apicoplast glutamyl-tRNA synthetase

$487,500
Malcolm John Gardner · J. Craig Venter Institute, Inc. · R01 · FY2017 · AI

MAOI-inspired activity probes to translate epigenetics and genetics into drugs

$487,500
Megan L Matthews · University Of Pennsylvania · DP1 · FY2022 · DA

ELF1 - Molecular mechanisms of a novel transcription factor with broad antiviral activity

$487,446
Meike Dittmann · New York University School Of Medicine · R01 · FY2021 · AI

Development Of Drugs Acting At Adenosine Receptors

$487,403
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK

Acquisition of a Q-TOF Mass Spectrometer

$487,380
James B Gloer · University Of Iowa · S10 · FY2007 · RR

Alzheimer's disease risk analyzed using population imaging genomics

$487,330
Paul M Thompson · University Of Southern California · R01 · FY2015 · AG

In Vitro and In Situ Engineering of Fibroblasts for Cardiac Repair

$487,302
Nenad Bursac · Duke University · R01 · FY2017 · HL

Vanderbilt Network Lead Academic Participating Site for the NCTN

$487,276
Jordan D Berlin · Vanderbilt University Medical Center · UG1 · FY2019 · CA

Vanderbilt Network Lead Academic Participating Site for the NCTN

$487,276
Jordan D Berlin · Vanderbilt University Medical Center · UG1 · FY2020 · CA

Molecular Basis for Lens Transparency

$487,264
Hassane S McHaourab · Vanderbilt University · R01 · FY2021 · EY

Dysregulation of mTOR Signaling in Fragile X Syndrome

$487,251
R. Suzanne Zukin · Albert Einstein College Of Medicine · R01 · FY2014 · MH

Development of a generalizable chemo-proteomics screening platform for small molecule degraders applied to HDACs

$487,238
Eric Sebastian Fischer · Dana-Farber Cancer Inst · R01 · FY2022 · CA

Epigenomic Regulation in Pancreatic Cell Growth

$487,218
Raul A Urrutia · Medical College Of Wisconsin · R01 · FY2021 · DK

Structure and Function of Integrase

$487,207
Institute For Cancer Research · R01 · FY2004 · AI

Technology and Database for Antimicrobial Identification

$487,187
Biolog, Inc. · R43 · FY2005 · AI

Gene Regulation in Memory Circuits as a Consequence of Polysubstance Use

$487,176
Karla R. Kaun · Brown University · R01 · FY2025 · DA

Antibiotic Drug Discovery

$487,166
Toni B. Kline · University Of Washington · U54 · FY2011 · AI

High-throughput screening platform for cancer drug discovery

$487,159
Michael Recht · Palo Alto Research Center · R21 · FY2016 · CA

Restoration of Tumor Suppression Activity in Malignant Melanoma

$487,128
David Joseph Weber · University Of Maryland Baltimore · R01 · FY2008 · CA